IL131917A0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- IL131917A0 IL131917A0 IL13191798A IL13191798A IL131917A0 IL 131917 A0 IL131917 A0 IL 131917A0 IL 13191798 A IL13191798 A IL 13191798A IL 13191798 A IL13191798 A IL 13191798A IL 131917 A0 IL131917 A0 IL 131917A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13809898A IL138098A (en) | 1997-03-24 | 1998-03-20 | Use of lamivudine or pharmaceutically acceptable derivatives thereof for the manufacture of pharmaceutical compositions for use in the treatment or prophylaxis of viral infections |
| IL13809800A IL138098A0 (en) | 1997-03-24 | 2000-08-25 | Use of pharmaceutical compositions containing lamivudine for treating viral infections |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4235397P | 1997-03-24 | 1997-03-24 | |
| GBGB9706295.4A GB9706295D0 (en) | 1997-03-26 | 1997-03-26 | Lamivudine formulation |
| PCT/EP1998/001626 WO1998042321A2 (en) | 1997-03-24 | 1998-03-20 | Liquid compositions comprising lamivudine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL131917A IL131917A (en) | 2001-01-11 |
| IL131917A0 true IL131917A0 (en) | 2001-03-19 |
Family
ID=26311267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13191798A IL131917A0 (en) | 1997-03-24 | 1998-03-20 | Pharmaceutical compositions |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US6004968A (pl) |
| EP (1) | EP0969815B1 (pl) |
| JP (1) | JP3264937B2 (pl) |
| KR (1) | KR100484695B1 (pl) |
| CN (1) | CN1191061C (pl) |
| AP (1) | AP1141A (pl) |
| AR (1) | AR011697A1 (pl) |
| AT (1) | ATE295150T1 (pl) |
| AU (1) | AU728461B2 (pl) |
| BG (1) | BG64690B1 (pl) |
| BR (1) | BR9808060B1 (pl) |
| CA (1) | CA2286126C (pl) |
| CO (1) | CO4980849A1 (pl) |
| CY (1) | CY2569B1 (pl) |
| CZ (1) | CZ298008B6 (pl) |
| DE (1) | DE69830154T2 (pl) |
| EA (1) | EA001990B1 (pl) |
| EE (1) | EE03996B1 (pl) |
| ES (1) | ES2239802T3 (pl) |
| HK (1) | HK1022853A1 (pl) |
| HN (1) | HN1998000045A (pl) |
| HR (1) | HRP980154B1 (pl) |
| HU (1) | HU225600B1 (pl) |
| ID (1) | ID29294A (pl) |
| IL (1) | IL131917A0 (pl) |
| IS (1) | IS2515B (pl) |
| MY (1) | MY116242A (pl) |
| NO (1) | NO326719B1 (pl) |
| NZ (1) | NZ337798A (pl) |
| PA (1) | PA8449301A1 (pl) |
| PE (1) | PE61699A1 (pl) |
| PL (1) | PL190505B1 (pl) |
| PT (1) | PT969815E (pl) |
| RS (1) | RS49772B (pl) |
| SI (1) | SI0969815T1 (pl) |
| SK (1) | SK283417B6 (pl) |
| SV (1) | SV1998000040A (pl) |
| TW (1) | TW536403B (pl) |
| UY (1) | UY24930A1 (pl) |
| WO (1) | WO1998042321A2 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333099A (en) | 1996-06-25 | 2000-06-23 | Glaxo Group Ltd | synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV |
| US6018044A (en) * | 1998-01-02 | 2000-01-25 | Roche Vitamins Inc. | Light screening compositions |
| US6432966B2 (en) * | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
| JP2003039582A (ja) * | 2001-07-19 | 2003-02-13 | Three M Innovative Properties Co | 湿潤防滑性シート及び湿潤防滑構造体 |
| US6855346B2 (en) * | 2001-10-05 | 2005-02-15 | Tzu-Sheng Wu | Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same |
| TWI275392B (en) * | 2002-04-08 | 2007-03-11 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
| WO2004075913A1 (ja) | 2003-02-28 | 2004-09-10 | Chugai Seiyaku Kabushiki Kaisha | タンパク質含有安定化製剤 |
| US20040228804A1 (en) * | 2003-05-16 | 2004-11-18 | Jones Alonzo H. | Nasal administration of xylitol to a non-human mammal |
| PE20060484A1 (es) * | 2004-07-14 | 2006-07-06 | Ucb Farchim Sa | Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina |
| CN100427082C (zh) * | 2005-08-02 | 2008-10-22 | 盛华（广州）医药科技有限公司 | 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用 |
| WO2009092002A1 (en) * | 2008-01-17 | 2009-07-23 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| RU2587782C1 (ru) * | 2015-01-19 | 2016-06-20 | Общество с ограниченной ответственностью "Трейдсервис" | Стабильная фармацевтическая композиция ламивудина |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| DK0513917T4 (da) * | 1991-05-16 | 2001-06-25 | Glaxo Group Ltd | Antivirale kombinationer indeholdende nukleosidanaloger |
| GB9111902D0 (en) * | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
| GB9503850D0 (en) * | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9605293D0 (en) * | 1996-03-13 | 1996-05-15 | Glaxo Group Ltd | Medicaments |
-
1998
- 1998-03-16 TW TW087103841A patent/TW536403B/zh not_active IP Right Cessation
- 1998-03-20 PA PA19988449301A patent/PA8449301A1/es unknown
- 1998-03-20 EP EP98919120A patent/EP0969815B1/en not_active Expired - Lifetime
- 1998-03-20 EE EEP199900440A patent/EE03996B1/xx unknown
- 1998-03-20 KR KR10-1999-7008690A patent/KR100484695B1/ko not_active IP Right Cessation
- 1998-03-20 DE DE69830154T patent/DE69830154T2/de not_active Expired - Lifetime
- 1998-03-20 AT AT98919120T patent/ATE295150T1/de active
- 1998-03-20 PE PE1998000203A patent/PE61699A1/es not_active IP Right Cessation
- 1998-03-20 MY MYPI98001227A patent/MY116242A/en unknown
- 1998-03-20 SV SV1998000040A patent/SV1998000040A/es active IP Right Grant
- 1998-03-20 BR BRPI9808060-1A patent/BR9808060B1/pt not_active IP Right Cessation
- 1998-03-20 NZ NZ337798A patent/NZ337798A/xx not_active IP Right Cessation
- 1998-03-20 CA CA002286126A patent/CA2286126C/en not_active Expired - Lifetime
- 1998-03-20 AP APAP/P/1999/001657A patent/AP1141A/en active
- 1998-03-20 ES ES98919120T patent/ES2239802T3/es not_active Expired - Lifetime
- 1998-03-20 SK SK1299-99A patent/SK283417B6/sk not_active IP Right Cessation
- 1998-03-20 ID IDW991096A patent/ID29294A/id unknown
- 1998-03-20 IL IL13191798A patent/IL131917A0/xx not_active IP Right Cessation
- 1998-03-20 CO CO98015975A patent/CO4980849A1/es unknown
- 1998-03-20 HU HU0002982A patent/HU225600B1/hu unknown
- 1998-03-20 HN HN1998000045A patent/HN1998000045A/es unknown
- 1998-03-20 EA EA199900757A patent/EA001990B1/ru not_active IP Right Cessation
- 1998-03-20 WO PCT/EP1998/001626 patent/WO1998042321A2/en active IP Right Grant
- 1998-03-20 PL PL98336038A patent/PL190505B1/pl unknown
- 1998-03-20 SI SI9830767T patent/SI0969815T1/xx unknown
- 1998-03-20 JP JP54442598A patent/JP3264937B2/ja not_active Expired - Lifetime
- 1998-03-20 CZ CZ0340399A patent/CZ298008B6/cs not_active IP Right Cessation
- 1998-03-20 US US09/044,896 patent/US6004968A/en not_active Expired - Lifetime
- 1998-03-20 CN CNB988051222A patent/CN1191061C/zh not_active Expired - Lifetime
- 1998-03-20 PT PT98919120T patent/PT969815E/pt unknown
- 1998-03-20 AU AU72084/98A patent/AU728461B2/en not_active Expired
- 1998-03-20 RS YUP-477/99A patent/RS49772B/sr unknown
- 1998-03-23 UY UY24930A patent/UY24930A1/es not_active IP Right Cessation
- 1998-03-23 HR HR980154A patent/HRP980154B1/xx not_active IP Right Cessation
- 1998-03-23 AR ARP980101317A patent/AR011697A1/es active IP Right Grant
-
1999
- 1999-09-17 IS IS5184A patent/IS2515B/is unknown
- 1999-09-23 NO NO994619A patent/NO326719B1/no not_active IP Right Cessation
- 1999-10-18 BG BG103818A patent/BG64690B1/bg unknown
-
2000
- 2000-04-07 HK HK00102154A patent/HK1022853A1/xx not_active IP Right Cessation
-
2006
- 2006-11-09 CY CY0600032A patent/CY2569B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9727053D0 (en) | Pharmaceutical compositions | |
| EG24118A (en) | Pharmaceutical compositions | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| CY2569B1 (en) | Pharmaceutical compositions | |
| GB9616672D0 (en) | Pharmaceutical compositions | |
| GB9610359D0 (en) | Pharmaceutical compositions | |
| GB9717444D0 (en) | Pharmaceutical composition | |
| IL131995A0 (en) | Gastric-retained pharmaceutical compositions | |
| GB9723985D0 (en) | Pharmaceutical compositions | |
| GB9717428D0 (en) | Pharmaceutical composition | |
| GB9726735D0 (en) | Pharmaceutical compositions | |
| GB9622681D0 (en) | Pharmaceutical compositions | |
| GB9606429D0 (en) | Pharmaceutical compositions | |
| HU9700632D0 (en) | Pharmaceutical compositions | |
| GB9613457D0 (en) | Pharmaceutical compositions | |
| GB9618376D0 (en) | Pharmaceutical compositions | |
| GB9717770D0 (en) | Pharmaceutical composition | |
| GB9610136D0 (en) | Pharmaceutical compositions | |
| GB9921495D0 (en) | Pharmaceutical compositions | |
| GB2321190B (en) | Pharmaceutical composition | |
| GB9726781D0 (en) | Pharmaceutical composition | |
| GB9714328D0 (en) | Pharmaceutical compositions | |
| GB9825499D0 (en) | Pharmaceutical compositions | |
| GB9710505D0 (en) | Pharmaceutical compositions | |
| GB9725563D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |